Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?

Impact · against what's priced in

The upcoming Q3 earnings report for Molina Healthcare is expected to confirm the current bearish trajectory, with projections for significant earnings and revenue declines. Because the market has already absorbed the 2026 earnings trough and near-term performance headwinds, these estimates are not catalysts for further price movement.

MOH−0.05

Already priced in

The price assumes

A trough in 2026 earnings, with the large Q4 2025 adjusted EPS loss of $2.75 already absorbed.

The projected 60.9% year-over-year decline in Q3 earnings and a 52.1% decrease for full-year 2026 align with the market's existing expectation of an earnings trough this year.

What MOH's price assumes · Sep 24

• revenue▲57%
• earnings▲12%
• healthcare
• guidance
• MOH
• eps

Top 2 movers · tap to explore